Document is current
Any future updates will be listed below
-
Authors
Lau, Chi Ieong
Wang, Yen-Feng
-
Funding
Funding for this research was provided by:
National Science and Technology Council (109-2314-B-075 -054; 110-2314-B-075 -041 -MY3)
Taipei Veterans General Hospital (V108C-092, V109C-096, V110C-111, V111C-161, V112C-078, V112D67-003-MY3)
- License Information
-
More Information
Article History
Accepted: 4 September 2024
First Online: 22 February 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: YFW has received personal fees as an advisor or a speaker from Allergan/AbbVie, Boehringer Ingelheim, Chugai, Eli Lilly, Hava Bio-Pharma, Lundbeck, Novartis, Orient EuroPharma, Pfizer, Sanofi, Teva, UCB, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. CIL reports no relevant conflicts of interest.
